We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

52 hedge funds and large institutions have $30.4M invested in Neos Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

8% more funds holding

Funds holding: 48 → 52 (+4)

15% less capital invested

Capital invested by funds: $35.9M → $30.4M (-$5.51M)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$2.3M
2
CCI
Columbus Circle Investors
+$286K
3
Morgan Stanley
Morgan Stanley
New York
+$246K
4
State Street
State Street
Massachusetts
+$244K
5
UBS Group
UBS Group
Switzerland
+$232K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$2.23M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.19M
3
BFA
BlackRock Fund Advisors
California
-$1.13M
4
WSA
Wall Street Associates
California
-$983K
5
PI
Putnam Investments
Massachusetts
-$670K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$145K +$168K +24,821 New
Charles Schwab
27
Charles Schwab
California
$126K – – –
Wells Fargo
28
Wells Fargo
California
$122K -$1.64K -243 -1%
CS
29
Credit Suisse
Switzerland
$91K +$35.4K +5,237 +51%
PCM
30
Prelude Capital Management
New York
$85K +$98.7K +14,587 New
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$76K +$19.5K +2,878 +28%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$74K -$4.06K -600 -5%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$61K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$56K +$64.7K +9,561 New
NFA
35
Nationwide Fund Advisors
Ohio
$50K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$49K +$33.9K +5,016 +137%
AIG
37
American International Group
New York
$46K -$149 -22 -0.3%
BA
38
BlackRock Advisors
Delaware
$23K – – –
Bank of America
39
Bank of America
North Carolina
$23K +$22.5K +3,327 +567%
Barclays
40
Barclays
United Kingdom
$22K +$26.2K +3,876 +4,507%
Legal & General Group
41
Legal & General Group
United Kingdom
$21K +$8.8K +1,300 +64%
TRCT
42
Tower Research Capital (TRC)
New York
$21K +$24.5K +3,622 New
MAM
43
Meeder Asset Management
Ohio
$18K +$21K +3,100 New
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$10K +$6.83K +1,010 +135%
PA
45
Perceptive Advisors
New York
$6K -$2.23M -329,537 -100%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$4.03K -$1.01K -150 -18%
Citigroup
47
Citigroup
New York
$4K -$25.2K -3,720 -86%
QCG
48
Quadrant Capital Group
Ohio
$4K +$5.58K +824 New
BlackRock
49
BlackRock
New York
$3K – – –
CHP
50
Cable Hill Partners
Oregon
$3K – – –
1
2
3

NEOS Hedge Fund Activity: Q4 2016 in Review

52 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2016, worth a combined $30.4M — down 15% from $35.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NEOS positions and 4 closed out — a net gain of 4 holders — while 18 added to existing stakes and 14 trimmed.

The largest buyer was Northern Trust, adding an estimated $2.3M. The largest seller was Perceptive Advisors, cutting an estimated $2.23M.

  • 52 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2016, up from 48 in Q3 2016.
  • Funds reported $30.4M of Neos Therapeutics, Inc stock for Q4 2016, down 15% quarter-over-quarter.
  • 8 funds opened new Neos Therapeutics, Inc positions in Q4 2016 and 4 closed out, a net change of +4 holders.
  • The largest Neos Therapeutics, Inc buyer in Q4 2016 was Northern Trust, an estimated $2.3M added.
  • The largest Neos Therapeutics, Inc seller in Q4 2016 was Perceptive Advisors, an estimated $2.23M sold.

Based on aggregated 13F filings for Q4 2016.